|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
ELB171652 |
| 003 |
FINmELB |
| 005 |
20220615121057.0 |
| 006 |
m o u |
| 007 |
cr cn||||||||| |
| 008 |
070809s2008 paua b 001 0 eng |
| 020 |
|
|
|z 9780781773287
|
| 035 |
|
|
|a (OCoLC)460659761
|
| 040 |
|
|
|a FINmELB
|c FINmELB
|d FINmELB
|
| 050 |
0 |
0 |
|a RC271.C5
|b C446 2008
|
| 060 |
0 |
0 |
|a 2007 M-796
|
| 060 |
1 |
0 |
|a QZ 267
|b C5186 2008
|
| 082 |
0 |
0 |
|a 616.99/4061
|2 22
|
| 096 |
|
|
|a QZ267
|b .C5186 2008
|
| 245 |
0 |
4 |
|a The chemotherapy source book /
|c editor, Michael C. Perry.
|
| 250 |
|
|
|a 4th ed.
|
| 260 |
|
|
|a Philadelphia :
|b Wolters Kluwer Health/Lippincott Williams & Wilkins,
|c c2008.
|
| 300 |
|
|
|a 1 online resource (xvi, 779 p.) :
|b ill.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Scientific basis of cancer chemotherapy -- Norton-simon hypothesis -- Drug resistance -- Principles of chemotherapy -- Clinical trials -- Hematopoietic growth factors -- Biologic response modifiers: principles of biotherapy -- Intraventricular and intrathecal therapy -- Intraperitoneal chemotherapy -- Continuous intravenous infusion chemotherapy -- Intraarterial chemotherapy -- Isolated regional therapy -- Hematopoietic stem cell transplantation -- Oral toxicity -- Dermatologic toxicity -- Extravasation -- Hypersensitivity reactions -- Ocular side effects of chemotherapy -- Cardiotoxicity of cancer therarpy -- Pulmonary toxicity of antineoplastic therapy -- Gastrointestinal complications of chemotherapy -- Hepatotoxicity of chemotherapeutic agents -- Renal and electrolyte abnormalities due to chemotherapy -- Chemotherapy-induced peripheral neuropathy -- Vascular toxicity of antineoplastic agents -- Second malignancies after chemotherapy -- Chemotherapy in pregnancy -- Gonadal complications and teratogenicity of cancer therapy -- Central venous access for chemotherapy -- Systemic therapy for advanced melanoma -- General issues in brain tumor chemotherapy -- Chemotherapy of head and neck cancer -- Chemotherapy of lung cancer -- Breast cancer -- Gastrointestinal cancer -- Endocrine tumors -- Chemotherapy of genitourinary cancers -- Chemotherapy of gynecologic cancers -- Chemotherapy of carcinoma of unknown primary site -- Chemotherapy of bone and soft tissue sarcomas -- Chemotherapy for pediatic solid tumors -- Chemotherapy of hodgkin's lymphoma -- Non-hodgkin's lymphoma -- Acute myeloid leukemia, aucte lymphoblastic leukemia, and chronic lymphocytic leukemia -- Chemotherapy of the myelodysplastic syndromes -- Management of myeloproliferative disorders and chronic myeloid leukemia -- Chemotherapy of multiple myeloma and other plasma cell disorders.
|5 FU
|5 FOFT
|
| 588 |
|
|
|a Description based on metadata supplied by the publisher and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Santa Fe, Arg.: elibro, 2022. Available via World Wide Web. Access may be limited to eLibro affiliated libraries.
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
| 650 |
|
0 |
|a Antineoplastic agents.
|
| 650 |
1 |
2 |
|a Neoplasms
|x drug therapy.
|
| 650 |
2 |
2 |
|a Antineoplastic Agents
|x therapeutic use.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Perry, Michael C.
|q (Michael Clinton),
|d 1945-
|
| 797 |
2 |
|
|a elibro, Corp.
|
| 856 |
4 |
0 |
|u https://elibro.uam.elogim.com/ereader/bidiuam/171652
|z Texto completo
|
